Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
13.08.25
/
50%
€104.00
Target price
13.08.26
€121.61
Performance (%)
72.12%
Price
28.11.25
€178.00
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Insmed Inc. has seen massive gains of 72.12%. This prediction currently runs until 13.08.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 2.326% | 2.326% |
| iShares Core DAX® | 2.705% | -1.771% |
| iShares Nasdaq 100 | 4.127% | -1.874% |
| iShares Nikkei 225® | 1.944% | -3.187% |
| iShares S&P 500 | 2.919% | -0.149% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $114.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat